Can a second drug wipe out stubborn breast cancer?
NCT ID NCT00877500
First seen Nov 11, 2025 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests whether the drug ixabepilone can help people with HER2-negative breast cancer whose tumors didn't fully disappear after standard chemotherapy. About 116 participants will either receive ixabepilone or be observed. The goal is to see if the drug can stop cancer from coming back by blocking cell division.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453-2699, United States
-
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.